SCHEMBL5463134

SCHEMBL5463134

CCCCC1CCN(C(=O)CCCc2cc3ccccc3o2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 2/20 0.44
GNAO1 P09471 2/20 0.44
GNAI1 P63096 2/20 0.44
PREP P48147 1/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
HPGD P15428 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
MAPK1 P28482 3/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 2/20 0.42
CHRM1 P11229 2/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
HTR1A P08908 1/20 0.41
CHRM5 P08912 1/20 0.41
ADRA2A P08913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5335284 0.81 DRD2 (0.55) CHRM1CHRM2CHRM4HTR1ACHRM5
SCHEMBL5345306 0.73 CHRM1 (0.61) ALDH1A1SMN1; SMN2HPGDRAB9ANPC1
SCHEMBL29594271 0.72 LOXL2 (0.56) SMN1; SMN2LMNAMAPTHTR1ADRD2
SCHEMBL1287509 0.72 LOXL2 (0.56) SMN1; SMN2LMNAMAPTHTR1ADRD2
SCHEMBL252581 0.71 MAPT (0.60) SMN1; SMN2MAPTHTR1ADRD2HDAC3
Hydrochloric Acid SCHEMBL28989961 0.71 LOXL2 (0.55) SMN1; SMN2MAPTHTR1ADRD2HDAC3
SCHEMBL7014940 0.71 CHRM1 (0.39) ALDH1A1KDM4ESMN1; SMN2HPGDRAB9A
SCHEMBL23804835 0.70 CYP1A2 (0.51) SMN1; SMN2RAB9ANPC1MAPK1DRD2
SCHEMBL13597091 0.70 HDAC3 (0.69) ALDH1A1KDM4ENPC1FAAHMEN1
SCHEMBL8688187 0.70 MAPT (0.63) SMN1; SMN2MAPTDRD2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155795-A1 MUSCARINIC AGONISTS ACADIA PHARMACEUTICALS INC. (US) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155795-A1 MUSCARINIC AGONISTS CHRM2, CHRM1, CHRM4 GNAI3 1568/4885GNAO1 303/4885GNAI1 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.